ZyVersa Therapeutics, Inc. (ZVSA)
NASDAQ: ZVSA · Real-Time Price · USD
0.6174
+0.0084 (1.38%)
At close: Apr 4, 2025, 4:00 PM
0.5999
-0.0175 (-2.84%)
After-hours: Apr 4, 2025, 7:58 PM EDT

ZyVersa Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1.533.145.90.330.17
Cash & Short-Term Investments
1.533.145.90.330.17
Cash Growth
-51.21%-46.84%1696.27%88.11%-
Prepaid Expenses
0.180.220.230.110.16
Other Current Assets
--0.240.38-
Total Current Assets
1.723.356.360.810.34
Property, Plant & Equipment
-0.010.120.030.04
Goodwill
--11.9--
Other Intangible Assets
18.6518.65100.09--
Long-Term Deferred Charges
0.06----
Other Long-Term Assets
0.180.10.050.290.31
Total Assets
20.622.11118.511.130.69
Accounts Payable
9.348.436.0322.31
Accrued Expenses
1.891.250.80.751.16
Current Portion of Long-Term Debt
---9.152.13
Current Portion of Leases
-0.010.11--
Current Income Taxes Payable
--0.11--
Other Current Liabilities
-0.511.151.731.96
Total Current Liabilities
11.2310.198.1913.637.56
Long-Term Debt
----1.69
Long-Term Deferred Tax Liabilities
0.850.8410.32--
Other Long-Term Liabilities
--0.330.330.33
Total Liabilities
12.0811.0418.8413.969.57
Common Stock
00000
Additional Paid-In Capital
121.16114.3104.5840.0735.92
Retained Earnings
-112.63-103.22-4.92-52.9-44.81
Treasury Stock
-0.01-0.01---
Total Common Equity
8.5211.0799.66-12.83-8.89
Shareholders' Equity
8.5211.0799.66-12.83-8.89
Total Liabilities & Equity
20.622.11118.511.130.69
Total Debt
-0.010.119.153.82
Net Cash (Debt)
1.533.135.79-8.82-3.64
Net Cash Growth
-51.07%-45.99%---
Net Cash Per Share
1.3832.090.25-3.65-53.94
Filing Date Shares Outstanding
2.570.830.1224.170.07
Total Common Shares Outstanding
2.510.410.0324.170.07
Working Capital
-9.52-6.84-1.83-12.81-7.22
Book Value Per Share
3.4027.333868.91-0.53-131.63
Tangible Book Value
-10.13-7.57-12.32-12.83-8.89
Tangible Book Value Per Share
-4.04-18.69-478.20-0.53-131.63
Machinery
-0.050.050.050.05
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q